Clinical Trials Directory

Trials / Sponsors / Watson Pharmaceuticals

Watson Pharmaceuticals

Industry · 30 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis
Hyperhidrosis
Phase 22013-12-01
WithdrawnEfficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
Leiomyomas
Phase 32012-04-01
CompletedPharmacokinetics, Metabolism, Efficacy, and Safety Study of Two Testosterone Matrix Transdermal Systems
Hypogonadism
Phase 22011-04-01
CompletedRandomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Admini
Prostate Cancer
Phase 42010-07-01
CompletedStudy of Silodosin to Facilitate Passage of Urinary Stones
Ureteral Calculi, Kidney Stones, Urolithiasis
Phase 22010-06-01
CompletedEfficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception
Contraceptive Usage
Phase 32010-05-01
CompletedDose Titration Investigation of the Pharmacokinetics of Testosterone Transdermal Systems in Hypogonadal Men
Hypogonadism
Phase 12010-04-01
CompletedEfficacy and Safety Study of Uracyst to Treat Interstitial Cystitis/Painful Bladder Syndrome
Interstitial Cystitis, Painful Bladder Syndrome
Phase 22009-07-01
CompletedEffects of Oxybutynin Topical Gel on Gastric Emptying
Healthy
Phase 12009-06-01
CompletedA Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia
Nocturia, Prostatic Hyperplasia
Phase 22009-01-01
CompletedCognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers
Healthy Volunteers
Phase 12008-09-01
CompletedUse of Silodosin to Treat Moderate to Severe Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Abacterial Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Phase 22008-09-01
CompletedA Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Intersti
Interstitial Cystitis
Phase 22007-09-01
CompletedComparison Between Effects of Two Iron Preparations on Protein in the Urine
Kidney Failure, Chronic, Anemia, Iron-Deficiency
Phase 12007-09-01
CompletedA Comparison of a New Drug to Treat Overactive Bladder vs. Placebo
Overactive Bladder
Phase 32006-06-01
CompletedEffect of Two Iron Preparations on Protein in the Urine
Kidney Failure, Chronic, Anemia, Iron-Deficiency
Phase 42006-06-01
CompletedThe Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months
Benign Prostatic Hyperplasia
Phase 32005-09-01
CompletedA New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Benign Prostatic Hyperplasia (BPH)
Phase 32005-05-01
CompletedA New Drug for Benign Prostatic Hyperplasia (BPH) Compared With Placebo
Benign Prostatic Hyperplasia
Phase 32005-05-01
CompletedA Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Co
Detrusor Hyperreflexia
Phase 42004-12-01
CompletedSafety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
Detrusor Hyperreflexia
Phase 42004-12-01
CompletedDRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Anemia, Iron-Deficiency, Kidney Failure, Chronic, Hemodialysis
Phase 42004-09-01
CompletedTransdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder
Overactive Bladder, Urinary Incontinence, Quality of Life
Phase 42004-05-01
Completed2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.
Iron Deficiency Anemia
Phase 2 / Phase 32003-12-01
CompletedStudy of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis
Anemia
Phase 42003-06-01
CompletedEffect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythr
Anemia, Iron-Deficiency, Kidney Failure, Chronic
Phase 42003-04-01
CompletedStudy of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients
Anemia
Phase 42003-04-01
CompletedEffect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients
Anemia, Iron-Deficiency, Kidney Failure, Chronic
Phase 42003-04-01
CompletedEffect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Anemia
Phase 42002-05-01
CompletedA Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women
Menopause
Phase 42002-01-01